1Sakane T,Suzuki N,Takada S,et al.B cell hyperactivity and its relation to distinct clinical features and the degree of disease activity in patients with systemic lupus erythematosus[].Arthritis and Rheumatism.1988
2Crispin JC,Martine A,De Pablo P,et al.Participation of the CD69 antigen in the T-cell activation process of patients with systemic lupus erythematosus[].Scandinavian Journal of Immunology.1998
3Valentjjn RM,Van Overhagen H,Hagerct HM,et al.The value of complement and immune complex determinations in monitoring disease activity in patients with systemic lupus erythematosus[].Arthritis and Rheumatism.1985
4Lorenz HM,Griinke M,Hieronymus T,et al.In vitro apoptosis and expression of apoptosis-related molecules in lymphocytes from patients with systemic lupus erythematosus and other autoimmune disease[].Arthritis and Rheumatism.1997
7[2]Drakesmith H, Chain B, Beverley P. How can dendritic cells cause autoimmune diease?[J] Immunol Today, 2000, 21(5): 214-217
8[3]Rouard H, Leon A, Klonjkowski B, et al. Adenoviral transduction of human "clinical grade" immatyre dendritic cells enhances costimulatory molecule expression and T-cell stimulatory capacity[J].J Immunol Meth, 2000, 241(1-2): 69-81.
9[4]Dubois B, Catherine M, Beatice V, et al. Critical role of IL-12 in dendritic cell-induced differentiation of nasive B lymphocytes[J]. J Immunol, 1998, 161(5): 2223-2231.
10[5]Blanco P, Palucha AK, Gill M, et al. Induction of dendritic cell differentiation by IFN-alpha in systemic lupus erythematosus [J].Science, 2001, 294(5546): 1540-1543.
